Quantcast

Latest Anthony Fauci Stories

2014-05-21 13:42:09

NIH Research by NIH Scientists, Grantees Identifies Leads for Further Study WHAT: Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS-CoV), a virus first detected in humans in 2012 that has since caused 614 laboratory-confirmed infections, including 181 that were fatal, according to the World Health Organization. The case count escalated sharply in the spring of this year, and...

2014-03-10 08:30:12

Multi-center collaboration aims to advance neutralizing antibody research from preclinical to clinical trials. SEATTLE, March 10, 2014 /PRNewswire/ -- Seattle BioMed today announced that it has received a seven year Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a vaccine that would elicit broadly neutralizing antibodies against HIV-1. Seattle BioMed will lead a consortium...

2014-02-06 09:45:52

Recent scientific advances offer promising areas for further exploration WHAT: Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in a more sustainable way, according to a new commentary from Anthony S. Fauci, M.D., director of the National...

Drugmaker Develops 100 Percent Effective Malaria Vaccine
2013-08-08 15:25:03

Lawrence LeBlond for redOrbit.com - Your Universe Online A team of scientists have for the first time developed a vaccine for malaria that has been found to be 100 percent effective in a small clinical trial. The vaccine, known as PfSPZ Vaccine, was developed by Sanaria Inc. in Rockville, Maryland and has so far been shown to be safe, generating an immune system response in healthy adults. Publishing the results of the early-stage clinical trial in the August 8 issue of Science,...

2012-09-20 16:33:47

Transmitted strains may have evolutionary advantage, NIH scientists suggest WHAT: A new study has found that even though HIV diversifies widely within infected individuals over time, the virus strains that ultimately are passed on through heterosexual transmission often resemble the strain of virus that originally infected the transmitting partner. Learning the characteristics of these preferentially transmitted HIV strains may help advance HIV prevention efforts, particularly with...

2012-07-23 14:49:38

Ending the global HIV/AIDS pandemic may be possible by implementing a multifaceted global effort that expands testing, treatment, and prevention programs, as well as meets the scientific challenges of developing an HIV vaccine and possibly a cure, according to a Viewpoint in the July 25 issue of JAMA, a theme issue on HIV/AIDS. Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Md., presented the article at a JAMA media briefing at...

FDA Approval Gives Us A Chance To Fight Bioterrorism, Plague
2012-04-30 12:33:18

The FDA has announced its approval of the antibacterial agent levofloxacin, or “Levaquin,” to treat and prevent the plague. Manufactured by Johnson & Johnson, Levaquin was approved under the FDA´s Animal Efficacy rule which allows results from animal testing to be studied if such tests on humans aren´t ethical or feasible. Why prevent the plague, and why now? Also known as Yersinia pestis, the plague is considered to be a bioterrorism threat. As such, the US...

2012-03-27 23:00:47

The FAIR Foundation´s CEO, Dr. Richard Darling, is strongly criticizing President Obama for his proposed 2013 budget request that would increase domestic HIV/AIDS funding by $800 million dollars. Darling points out that US taxpayers have already spent well over one third of a trillion–yes, trillion–dollars on HIV/AIDS, including the $28 billion 2012 budget request, which has resulted in a plummeting death rate exemplified by the 99 percent decline in deaths of...

2012-03-20 11:25:48

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'